123 related articles for article (PubMed ID: 27127393)
21. Fracture incidence in pre- and postmenopausal women after completion of adjuvant hormonal therapy for breast cancer.
Koopal C; Janssen-Heijnen ML; van de Wouw AJ; van den Bergh JP
Breast; 2015 Apr; 24(2):153-8. PubMed ID: 25618224
[TBL] [Abstract][Full Text] [Related]
22. Bone health management of Australian breast cancer survivors receiving hormonal therapy.
Roberts R; Miller M; O'Callaghan M; Koczwara B
Intern Med J; 2015 Nov; 45(11):1182-5. PubMed ID: 26348867
[TBL] [Abstract][Full Text] [Related]
23. Osteopenia and osteoporosis in women with breast cancer.
Ramaswamy B; Shapiro CL
Semin Oncol; 2003 Dec; 30(6):763-75. PubMed ID: 14663777
[TBL] [Abstract][Full Text] [Related]
24. A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians.
Huiart L; Ferdynus C; Giorgi R
Breast Cancer Res Treat; 2013 Feb; 138(1):325-8. PubMed ID: 23400580
[No Abstract] [Full Text] [Related]
25. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
Schmitz KH; Prosnitz RG; Schwartz AL; Carver JR
Cancer; 2012 Apr; 118(8 Suppl):2270-6. PubMed ID: 22488701
[TBL] [Abstract][Full Text] [Related]
26. Influence of histology on the effectiveness of adjuvant chemotherapy in patients with hormone receptor positive invasive breast cancer.
Truin W; Voogd AC; Vreugdenhil G; van der Sangen MJ; van Beek MW; Roumen RM
Breast; 2011 Dec; 20(6):505-9. PubMed ID: 21665471
[TBL] [Abstract][Full Text] [Related]
27. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors.
Knobf MT
Oncologist; 2006 Feb; 11(2):96-110. PubMed ID: 16476831
[TBL] [Abstract][Full Text] [Related]
28. Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors.
Chlebowski RT; Schottinger JE; Shi J; Chung J; Haque R
Cancer; 2015 Jul; 121(13):2147-55. PubMed ID: 25757699
[TBL] [Abstract][Full Text] [Related]
29. Mental Health Comorbidities and Elevated Risk of Opioid Use in Elderly Breast Cancer Survivors Using Adjuvant Endocrine Treatments.
Desai R; Camacho F; Tan X; LeBaron V; Blackhall L; Balkrishnan R
J Oncol Pract; 2019 Sep; 15(9):e777-e786. PubMed ID: 31322988
[TBL] [Abstract][Full Text] [Related]
30. Hormonal approaches to breast cancer treatment and prevention: an overview.
Vogel CL
Semin Oncol; 1996 Aug; 23(4 Suppl 9):2-9. PubMed ID: 8824459
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer update.
Kuter I
Oncologist; 2000; 5(4):285-92. PubMed ID: 10964995
[TBL] [Abstract][Full Text] [Related]
32. Quality of life of Croatian breast cancer patients receiving adjuvant treatment--comparison to long-term breast cancer survivors.
Murgić J; Soldić Z; Vrljić D; Samija I; Kirac I; Bolanca A; Kusić Z
Coll Antropol; 2012 Dec; 36(4):1335-41. PubMed ID: 23390830
[TBL] [Abstract][Full Text] [Related]
33. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy.
Markiewicz DA; Schultz DJ; Haas JA; Harris EE; Fox KR; Glick JH; Solin LJ
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):661-8. PubMed ID: 8690631
[TBL] [Abstract][Full Text] [Related]
34. The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures.
Nuver J; Smit AJ; Postma A; Sleijfer DT; Gietema JA
Cancer Treat Rev; 2002 Aug; 28(4):195-214. PubMed ID: 12363460
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant therapy of node-negative breast cancer.
Hall PD; Lesher BA; Hall RK
Ann Pharmacother; 1995 Mar; 29(3):289-98. PubMed ID: 7606076
[TBL] [Abstract][Full Text] [Related]
36. Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.
Carlson RW; Henderson IC
Breast Cancer Res Treat; 2003; 80 Suppl 1():S19-26; discussion S27-8. PubMed ID: 14535531
[TBL] [Abstract][Full Text] [Related]
37. Breast Cancer and the Obstetrician-Gynecologist: A Focus on Screening, Risk Assessment and Treatment of Survivors With Genitourinary Syndrome of Menopause.
Jasra B; Samiian L; Kaunitz AM
Clin Obstet Gynecol; 2019 Dec; 62(4):634-643. PubMed ID: 31259841
[TBL] [Abstract][Full Text] [Related]
38. Women's experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour.
Cahir C; Dombrowski SU; Kelly CM; Kennedy MJ; Bennett K; Sharp L
Support Care Cancer; 2015 Nov; 23(11):3115-30. PubMed ID: 25744290
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant aromatase inhibitors following tamoxifen for early-stage breast cancer in postmenopausal women: what do we really know?
Chung CT; Carlson RW
Clin Breast Cancer; 2004 Sep; 5 Suppl 1():S18-23. PubMed ID: 15347435
[TBL] [Abstract][Full Text] [Related]
40. Hormone replacement therapy and the risk of breast cancer: assessment of therapy acceptance in a cohort of previously treated breast cancer patients.
Anelli A; Gimenez DL; Rocha AP; de Abreu CM; Freitas HC
Rev Hosp Clin Fac Med Sao Paulo; 2003; 58(2):91-6. PubMed ID: 12845361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
